Ushbu ish iqtibos qilgan ishlar

236 ta ish

Ish: Advancements in risk stratification and management strategies in primary cardiovascular prevention

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
François Mach, Colin Baigent, Alberico L. Catapano +87
Maqola20197 iqtibos
ABI
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders +97
Maqola20217 iqtibos
ABI
General Cardiovascular Risk Profile for Use in Primary Care
Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina +4
Maqola20086 iqtibos
ABI
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller +9
Maqola20185 iqtibos
ABI
From C-Reactive Protein to Interleukin-6 to Interleukin-1
Paul M. Ridker
Sharh maqola20164 iqtibos
ABI
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham +23
Sharh maqola20174 iqtibos
ABI
Atherosclerosis
Peter Libby, Julie E. Buring, Lina Badimón +5
Sharh maqola20194 iqtibos
ABI
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad, Connor A. Emdin, Amit Kiran +6
Sharh maqola20153 iqtibos
ABI
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
Gerald S. Berenson, Sathanur R. Srinivasan, Weihang Bao +3
Maqola19983 iqtibos
ABI
Effects of blood pressure-lowering on outcome incidence in hypertension
Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti
Sharh maqola20153 iqtibos
ABI
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso, Stephen C. Bain, Agostino Consoli +12
Boshqa20163 iqtibos
ABI
Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
Chenhan Ma, Alison Avenell, Mark J Bolland +6
Sharh maqola20173 iqtibos
ABI
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano +96
Sharh maqola20193 iqtibos
ABI
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19
Maqola20223 iqtibos
ABI
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett +14
Maqola20132 iqtibos
ABI
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano +18
Maqola20152 iqtibos
ABI
A systematic review and meta-analysis on the therapeutic equivalence of statins
T.-C. Weng, Yea Huei Kao Yang, Sung‐Jan Lin +1
Sharh maqola20092 iqtibos
ABI
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Yoav Ben‐Shlomo, Melissa Spears, Chris Boustred +28
Sharh maqola20132 iqtibos
ABI
Measurement and Interpretation of the Ankle-Brachial Index
Victor Aboyans, Michael H. Criqui, Pierre Abraham +14
Sharh maqola20122 iqtibos
ABI
Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
Clara K Chow, Sanjit S. Jolly, Rao Ps +3
Maqola20102 iqtibos
ABI
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford +5
Maqola19952 iqtibos
ABI
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C Baigent, Colin Baigent, Lisa Blackwell +8
Sharh maqola20102 iqtibos
ABI
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12
Maqola20162 iqtibos
ABI
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
Michael G. Silverman, Brian A. Ference, Kyungah Im +5
Sharh maqola20162 iqtibos
ABI
A Test in Context: Lipoprotein(a)
Sotirios Tsimikas
Sharh maqola20172 iqtibos
ABI